New study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes…
published last week, which found that Ozempic could lower the risk of dementia and a range of other mental problems compared with other existing treatments for patients with diabetes. What's more, researchers found that Ozempic cut nicotine dependence in those patients.
The study relied on medical records from more than 100,000 U.S. diabetes patients, including more than 20,000 who were prescribed semaglutide between December 2017 and May 2021.and Boehringer Ingelheim's Jardiance, or empagliflozin. They compared the risks of 22 neurological and psychiatric outcomes within one year of treatment on the different diabetes drugs.
"Our results suggest that semaglutide use could extend beyond managing diabetes, potentially offering unexpected benefits in the treatment and prevention of cognitive decline and substance misuse," Dr. Riccardo De Giorgi, clinical lecturer at the University of Oxford and lead author of the study, said in a
UnitedHealth reported $98.86 billion in revenue for the quarter, narrowly edging out the $98.84 billion expected by analysts, according to LSEG. The company's adjusted earnings per share for the period came in at $6.80, while Wall Street was expecting $6.66 per share.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study findsType 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study.
Read more »
Ozempic's popularity leads to shortages for people with Type 2 diabetesDrugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.
Read more »
Ozempic's popularity leads to shortages for people with Type 2 diabetesDrugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.
Read more »
‘Ozempic babies’: Popular diabetes drugs linked to surprise pregnanciesScientists believe that we are 'in a data-free zone' with respect to fertility and GLP-1 agonists like Ozempic and Wegovy.
Read more »
‘Healthy’ kids’ foods that are not healthyOne in five kids and adolescents in the U.S. is obese and it’s considered a serious public health problem.
Read more »
Healthy Leaders Build Healthy CompaniesI am a doctor uncovering the secrets of workplace wellness and human performance. As an experienced management consultant and the Physician Lead of Advisory Services at Cleveland Clinic Canada, I advise global C-suite executives on people strategies at the intersection of health and business.
Read more »